Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Clovis, California 93611


Purpose:

Pregabalin is an alpha-2 delta ligand approved for the treatment of neuropathic pain, however, not all patients will respond to this drug. This study will compare the efficacy of pregabalin when administered with an experimental drug PF-00489791, in patients with post-herpetic neuralgia. The efficacy of this combination will be compared to pregabalin alone.


Criteria:

Inclusion Criteria: - Male or female of non-childbearing potential - Pain present for more than 3 months after healing of herpes zoster skin rash - VAS score of >=40mm at screening and baseline visits Exclusion Criteria: - Patients with pain conditions which might impair the assessment of postherpetic neuralgia - Skin conditions in the affected dermatome that could alter sensation other than postherpetic neuralgia - History or diagnosis of DSM IV major depressive disorder


NCT ID:

NCT00599638


Primary Contact:

Study Director
Pfizer CT.gov Call Center
Pfizer


Backup Contact:

N/A


Location Contact:

Clovis, California 93611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.